In announcing that branded or patented drugs would be hit with 100 percent tariffs on Oct. 1, Trump also said drugmakers could escape the penalties if they have a U.S.-based pharmaceutical manufacturing plant for which ground has been broken, or is currently under construction.

a host of federally funded healthcare and nutrition programs that serve low-income Americans will be scaled back, revamped with expanded work requirements and other restrictions or canceled altogether if individual states can’t find alternate funding sources.

Millions of Americans who could benefit from GLP-1 weight-loss drugs are caught in the middle of a battle between drug companies and insurers over their costs, leaving them without coverage even as evidence mounts that the drugs could stave off expensive health complications in the future. Insurance coverage for the drugs has barely budged in the ...

Medicare beneficiaries stand to lose access to two key virtual care programs that the federal government has offered since the start of the pandemic if the government shuts down Tuesday at midnight. The Medicare telehealth waivers and Acute Hospital at Home programs are set to expire Oct. 1 unless Congress passes a short-term government funding ...

With the Trump administration scaling back federal efforts to protect Americans from medical bills they can’t pay, advocates for patients and consumers have shifted their work to contain the nation’s medical debt problem to state Capitols. Despite progress in some mostly blue states this year, however, recent setbacks in more conservative legislatures underscore the persistent ...

The Trump administration projects average Medicare Advantage (MA) premiums will decline slightly for the 2026 plan year. The Centers for Medicare & Medicaid Services (CMS) announced Friday that the average monthly premium across all types of MA coverage is set to be $14, down from $16.40 in 2025. This includes MA plans with prescription drug coverage as ...